SAN DIEGO--(BUSINESS WIRE)--In a joint effort to provide lower cost and more defined reagents and media to the cell and gene therapy market, Nucleus Biologics, The Cell Performance Company™, a leading ...
Recombinant protein vaccines, which are obtained by conventional genetic engineering, are based on the proteins of target pathogens that can activate our immune systems. Unlike other types of vaccines ...
TOULOUSE, France & LAKELAND, Mich.--(BUSINESS WIRE)--Regulatory News: ABIONYX Pharma, (FR0012616852 - ABNX - PEA PME eligible), a new generation biotech company dedicated to the discovery and ...
WASHINGTON & NORWICH, Conn.--(BUSINESS WIRE)-- Arlington Capital Partners (“Arlington”), a Washington, D.C.-area private investment firm specializing in government regulated industries, today ...
Proteins and their many interactions play a crucial role in biological systems. Detailed characterization of these interactions is important to uncover disease processes and develop therapeutic ...
JONESBORO, Ark., Feb. 14, 2023 /PRNewswire/ -- GreenLab, Inc. announces launch of the biotech startup's proprietary vector technology platform. GreenLab Vector Technology (GVT) greens recombinant ...
Proteins are the fundamental building blocks of life, and they are the essential products of molecular biology’s core dogma. Proteins play a variety of roles in the body, including catalyzing ...
The global growth factors market is growing steadily, expected to be valued at approximately US$2.5 billion in 2026 and projected to reach US$3.7 billion ...
Novavax (NVAX) announced that it has signed a definitive agreement to sell its manufacturing facility in Bohumil, Czech Republic to Novo Nordisk (NVO) for $200M. The agreement includes a transfer of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results